Long-term cognitive safety of achieving very low LDL cholesterol with evolocumab
Zimerman A, O’Donoghue ML, Ran X, et al.
NEJM Evid. 2025;4(1):EVIDoa2400112.
Leggi
Breaking news
Conceiving during the first postoperative year after bariatric surgery: a retrospective study of pregnancy outcomes
Kaukonen S, Pajula S, Gissler M, et al.
BMC Pregnancy Childbirth. 2024(1):862.
Leggi
Efficacy and safety of glucagon-like peptide-1 receptor agonists for weight loss among adults without diabetes: a systematic review of randomized controlled trials
Moiz A, Filion KB, Toutounchi H, et al.
Ann Intern Med. Pub. online 7 Jan 2025.
Leggi
Automated insulin delivery in older adults with type 1 diabetes
Kudva YC, Henderson RJ, Kanapka LG, et al.
NEJM Evid. 2025;4(1):EVIDoa2400200.
Leggi
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes
23/12/2024
Leggi
AIFA: Attivazione web e pubblicazione schede di monitoraggio – PT web «Vazkepa» (icosapent etile)
16/12/2024
Leggi
The effect of automated insulin delivery system use on diabetes distress in people with type 1 diabetes and their caregivers: A systematic review and meta-analysis
Canha D, McMahon V, Schmitz S, et al.
Diabet Med. 2024:e15503.
Leggi
Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes
Shapiro MR, Tallon EM, Brown ME, et al.
Diabetologia. Pub. online 19 Dec 2024.
Leggi
AIFA: Riclassificazione del medicinale per uso umano «Vazkepa» (icosapent etile) in classe A (GU Serie Generale n.293 del 14-12-2024)
16/12/2024
Leggi
Effectiveness of semaglutide and tirzepatide in overweight and obese adults with type 1 diabetes
Snell-Bergeon JK, Kaur G, Renner D, et al.
Diabetes Technol Ther. Pub. online 2 Jan 2025.
Leggi